Genetic variability in pharmacokinetics of tyrosine kinase inhibitors in Pakistani chronic myeloid leukemia patients and its association with resistance to TKIs
Asma Khan
Genetic variability in pharmacokinetics of tyrosine kinase inhibitors in Pakistani chronic myeloid leukemia patients and its association with resistance to TKIs - Islamabad (unpublished) 2024 - xii, 146 p. : ill., Col. ; 30 cm. +CD
Submitted in partial fulfillment of the requirement for the degree of Doctor of Philosophy in Pharmacology to the Faculty of Health & Medical Sciences Includes bibliographical references and Annexures Thesis Supervisor: Prof. Dr. Akbar Waheed
Thesis (Ph.D)--Riphah International University, 2024
English
Pharmacology--Chronic myeloid leukemia--Philadelphia chromosome--Tyrosine kinase--FHMS
615.1 / ASM
Genetic variability in pharmacokinetics of tyrosine kinase inhibitors in Pakistani chronic myeloid leukemia patients and its association with resistance to TKIs - Islamabad (unpublished) 2024 - xii, 146 p. : ill., Col. ; 30 cm. +CD
Submitted in partial fulfillment of the requirement for the degree of Doctor of Philosophy in Pharmacology to the Faculty of Health & Medical Sciences Includes bibliographical references and Annexures Thesis Supervisor: Prof. Dr. Akbar Waheed
Thesis (Ph.D)--Riphah International University, 2024
English
Pharmacology--Chronic myeloid leukemia--Philadelphia chromosome--Tyrosine kinase--FHMS
615.1 / ASM